Ani Pharmaceuticals (ANIP) Goodwill & Intangibles (2012 - 2026)

Ani Pharmaceuticals has disclosed Goodwill & Intangibles across 15 years of filings, most recently posting $512.3 million for Q2 2026.

• In Q2 2026, Goodwill & Intangibles fell 11.8% year-over-year to $512.3 million; the TTM figure through Jun 2026 stood at $512.3 million (down 11.8% YoY), while the FY2025 annual figure was $542.0 million, down 9.94% from the prior year.
• Goodwill & Intangibles came in at $512.3 million for Q2 2026 at Ani Pharmaceuticals, down from $529.6 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $630.3 million in Q3 2024 to a low of $211.3 million in Q2 2024.
• Average Goodwill & Intangibles over 5 years is $452.6 million, with a median of $529.2 million recorded in 2022.
• Year-over-year, Goodwill & Intangibles surged 208.37% in 2022 and tumbled 58.14% in 2024.
• Over 5 years, Goodwill & Intangibles stood at $279.9 million in 2022, then slipped by 15.23% to $237.2 million in 2023, then surged by 153.69% to $601.8 million in 2024, then decreased by 9.94% to $542.0 million in 2025, then slipped by 5.47% to $512.3 million in 2026.
• Per Business Quant data, the three most recent Goodwill & Intangibles figures were $512.3 million in Q2 2026, $529.6 million in Q1 2026, and $542.0 million in Q4 2025.